Key Med-tech trends for 2021: regulatory sluggishness puts a brake on advances in artificial intelligence and machine learning

A look back as we move towards 2022

Regulators around the world have had their hands full in 2020 and 2021 to respond to the COVID-19 pandemic, but that’s just one reason artificial intelligence regulatory frameworks are lagging behind. . Several regulatory proposals have been launched, but one of them suggests a need for regulatory harmonization, a requirement that seems certain to add even more brake to a process that is already years behind the technology.

BioWorld MedTech Regulatory Artificial intelligence Digital health FDA FTC

Leave a Comment